Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD). The present study aimed to validate these AD conversion-related patterns (ADCRPs) a...
Gespeichert in:
| Veröffentlicht in: | The Journal of nuclear medicine (1978) Jg. 62; H. 6; S. 855 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.06.2021
|
| Schlagworte: | |
| ISSN: | 1535-5667, 1535-5667 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD). The present study aimed to validate these AD conversion-related patterns (ADCRPs) against neuropathologic findings.
We included patients from the Alzheimer's Disease Neuroimaging Initiative who underwent autopsy and for whom
F-FDG PET (30 AD, 6 MCI, 2 cognitively normal) and amyloid-β (Aβ) PET (17 AD, 3 MCI, 2 cognitively normal) were available. Pattern expression scores (PESs) of the
F-FDG- and Aβ-ADCRP were compared with Braak tangle stage and Thal amyloid phase, respectively. Mean
F-FDG uptake and mean
F-AV-45 SUV ratio (SUVr) in regions of hypometabolism and elevated amyloid load typical of AD, respectively, were used as volume-of-interest-based PET measures. The diagnostic performance for identifying none-to-low vs. intermediate-to-high AD neuropathologic change (ADNC) was assessed for all biomarkers.
We observed significant associations between PES of
F-FDG-ADCRP and Braak stage (ρ > 0.48,
< 0.005) and between PES of Aβ-ADCRP and Thal phase (ρ > 0.66,
< 0.001). PES of
F-FDG-ADCRP, PES of Aβ-ADCRP, and their combination identified intermediate-to-high ADNC with an area under the receiver-operating-characteristic curve (AUC) of 0.80, 0.95, and 0.98 (
= 22), respectively. Mean
F-FDG uptake and mean
F-AV-45 SUVr in AD-typical regions were also significantly associated with Braak stage (|ρ| > 0.45,
< 0.01) and Thal phase (ρ > 0.55,
< 0.01), respectively. Volume-of-interest-based PET measures discriminated between ADNC stages with an AUC of 0.79, 0.88, and 0.90 for mean
F-FDG uptake, mean
F-AV-45 SUVr, and their combination (
= 22), respectively. Contemplating all subjects with available
F-FDG PET and neuropathology information (
= 38), PES of
F-FDG-ADCRP was a significant predictor of intermediate-to-high ADNC (AUC = 0.72), whereas mean
F-FDG uptake was not (AUC = 0.66), although the difference between methods was not significant.
PES of
F-FDG-ADCRP, a measure of neurodegeneration, shows close correspondence with the extent of tau pathology, as assessed by Braak tangle stage. PES of Aβ-ADCRP is a valid biomarker of underlying amyloid pathology, as demonstrated by its strong correlation with Thal phase. The combination of ADCRPs performed better than
F-FDG-ADCRP alone, although there was only negligible improvement compared with Aβ-ADCRP. |
|---|---|
| AbstractList | Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD). The present study aimed to validate these AD conversion-related patterns (ADCRPs) against neuropathologic findings.
We included patients from the Alzheimer's Disease Neuroimaging Initiative who underwent autopsy and for whom
F-FDG PET (30 AD, 6 MCI, 2 cognitively normal) and amyloid-β (Aβ) PET (17 AD, 3 MCI, 2 cognitively normal) were available. Pattern expression scores (PESs) of the
F-FDG- and Aβ-ADCRP were compared with Braak tangle stage and Thal amyloid phase, respectively. Mean
F-FDG uptake and mean
F-AV-45 SUV ratio (SUVr) in regions of hypometabolism and elevated amyloid load typical of AD, respectively, were used as volume-of-interest-based PET measures. The diagnostic performance for identifying none-to-low vs. intermediate-to-high AD neuropathologic change (ADNC) was assessed for all biomarkers.
We observed significant associations between PES of
F-FDG-ADCRP and Braak stage (ρ > 0.48,
< 0.005) and between PES of Aβ-ADCRP and Thal phase (ρ > 0.66,
< 0.001). PES of
F-FDG-ADCRP, PES of Aβ-ADCRP, and their combination identified intermediate-to-high ADNC with an area under the receiver-operating-characteristic curve (AUC) of 0.80, 0.95, and 0.98 (
= 22), respectively. Mean
F-FDG uptake and mean
F-AV-45 SUVr in AD-typical regions were also significantly associated with Braak stage (|ρ| > 0.45,
< 0.01) and Thal phase (ρ > 0.55,
< 0.01), respectively. Volume-of-interest-based PET measures discriminated between ADNC stages with an AUC of 0.79, 0.88, and 0.90 for mean
F-FDG uptake, mean
F-AV-45 SUVr, and their combination (
= 22), respectively. Contemplating all subjects with available
F-FDG PET and neuropathology information (
= 38), PES of
F-FDG-ADCRP was a significant predictor of intermediate-to-high ADNC (AUC = 0.72), whereas mean
F-FDG uptake was not (AUC = 0.66), although the difference between methods was not significant.
PES of
F-FDG-ADCRP, a measure of neurodegeneration, shows close correspondence with the extent of tau pathology, as assessed by Braak tangle stage. PES of Aβ-ADCRP is a valid biomarker of underlying amyloid pathology, as demonstrated by its strong correlation with Thal phase. The combination of ADCRPs performed better than
F-FDG-ADCRP alone, although there was only negligible improvement compared with Aβ-ADCRP. Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD). The present study aimed to validate these AD conversion-related patterns (ADCRPs) against neuropathologic findings. Methods: We included patients from the Alzheimer's Disease Neuroimaging Initiative who underwent autopsy and for whom 18F-FDG PET (30 AD, 6 MCI, 2 cognitively normal) and amyloid-β (Aβ) PET (17 AD, 3 MCI, 2 cognitively normal) were available. Pattern expression scores (PESs) of the 18F-FDG- and Aβ-ADCRP were compared with Braak tangle stage and Thal amyloid phase, respectively. Mean 18F-FDG uptake and mean 18F-AV-45 SUV ratio (SUVr) in regions of hypometabolism and elevated amyloid load typical of AD, respectively, were used as volume-of-interest-based PET measures. The diagnostic performance for identifying none-to-low vs. intermediate-to-high AD neuropathologic change (ADNC) was assessed for all biomarkers. Results: We observed significant associations between PES of 18F-FDG-ADCRP and Braak stage (ρ > 0.48, P < 0.005) and between PES of Aβ-ADCRP and Thal phase (ρ > 0.66, P < 0.001). PES of 18F-FDG-ADCRP, PES of Aβ-ADCRP, and their combination identified intermediate-to-high ADNC with an area under the receiver-operating-characteristic curve (AUC) of 0.80, 0.95, and 0.98 (n = 22), respectively. Mean 18F-FDG uptake and mean 18F-AV-45 SUVr in AD-typical regions were also significantly associated with Braak stage (|ρ| > 0.45, P < 0.01) and Thal phase (ρ > 0.55, P < 0.01), respectively. Volume-of-interest-based PET measures discriminated between ADNC stages with an AUC of 0.79, 0.88, and 0.90 for mean 18F-FDG uptake, mean 18F-AV-45 SUVr, and their combination (n = 22), respectively. Contemplating all subjects with available 18F-FDG PET and neuropathology information (n = 38), PES of 18F-FDG-ADCRP was a significant predictor of intermediate-to-high ADNC (AUC = 0.72), whereas mean 18F-FDG uptake was not (AUC = 0.66), although the difference between methods was not significant. Conclusion: PES of 18F-FDG-ADCRP, a measure of neurodegeneration, shows close correspondence with the extent of tau pathology, as assessed by Braak tangle stage. PES of Aβ-ADCRP is a valid biomarker of underlying amyloid pathology, as demonstrated by its strong correlation with Thal phase. The combination of ADCRPs performed better than 18F-FDG-ADCRP alone, although there was only negligible improvement compared with Aβ-ADCRP.Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD). The present study aimed to validate these AD conversion-related patterns (ADCRPs) against neuropathologic findings. Methods: We included patients from the Alzheimer's Disease Neuroimaging Initiative who underwent autopsy and for whom 18F-FDG PET (30 AD, 6 MCI, 2 cognitively normal) and amyloid-β (Aβ) PET (17 AD, 3 MCI, 2 cognitively normal) were available. Pattern expression scores (PESs) of the 18F-FDG- and Aβ-ADCRP were compared with Braak tangle stage and Thal amyloid phase, respectively. Mean 18F-FDG uptake and mean 18F-AV-45 SUV ratio (SUVr) in regions of hypometabolism and elevated amyloid load typical of AD, respectively, were used as volume-of-interest-based PET measures. The diagnostic performance for identifying none-to-low vs. intermediate-to-high AD neuropathologic change (ADNC) was assessed for all biomarkers. Results: We observed significant associations between PES of 18F-FDG-ADCRP and Braak stage (ρ > 0.48, P < 0.005) and between PES of Aβ-ADCRP and Thal phase (ρ > 0.66, P < 0.001). PES of 18F-FDG-ADCRP, PES of Aβ-ADCRP, and their combination identified intermediate-to-high ADNC with an area under the receiver-operating-characteristic curve (AUC) of 0.80, 0.95, and 0.98 (n = 22), respectively. Mean 18F-FDG uptake and mean 18F-AV-45 SUVr in AD-typical regions were also significantly associated with Braak stage (|ρ| > 0.45, P < 0.01) and Thal phase (ρ > 0.55, P < 0.01), respectively. Volume-of-interest-based PET measures discriminated between ADNC stages with an AUC of 0.79, 0.88, and 0.90 for mean 18F-FDG uptake, mean 18F-AV-45 SUVr, and their combination (n = 22), respectively. Contemplating all subjects with available 18F-FDG PET and neuropathology information (n = 38), PES of 18F-FDG-ADCRP was a significant predictor of intermediate-to-high ADNC (AUC = 0.72), whereas mean 18F-FDG uptake was not (AUC = 0.66), although the difference between methods was not significant. Conclusion: PES of 18F-FDG-ADCRP, a measure of neurodegeneration, shows close correspondence with the extent of tau pathology, as assessed by Braak tangle stage. PES of Aβ-ADCRP is a valid biomarker of underlying amyloid pathology, as demonstrated by its strong correlation with Thal phase. The combination of ADCRPs performed better than 18F-FDG-ADCRP alone, although there was only negligible improvement compared with Aβ-ADCRP. |
| Author | Sörensen, Arnd Meyer, Philipp T Blazhenets, Ganna Frings, Lars |
| Author_xml | – sequence: 1 givenname: Ganna surname: Blazhenets fullname: Blazhenets, Ganna email: ganna.blazhenets@uniklinik-freiburg.de organization: Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany ganna.blazhenets@uniklinik-freiburg.de – sequence: 2 givenname: Lars surname: Frings fullname: Frings, Lars organization: Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany – sequence: 3 givenname: Arnd surname: Sörensen fullname: Sörensen, Arnd organization: Department of Nuclear Medicine, University of Freiburg Medical Center, Freiburg, Germany – sequence: 4 givenname: Philipp T surname: Meyer fullname: Meyer, Philipp T |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33097630$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkL1OwzAYRS1URGnhAViQR5aUxI7tZCyh_EgFKlrmyHY-p6mcOMTJ0LcnEkViuvdKR2e4MzRpXAMI3UThgqRc3B-aoYZiEZFxMyISeoYuI0ZZwDgXk399imbeH8Iw5EmSXKAppWEqOA0vUbnpqkZXrbRB5up29Dc9XjbSHn3lgwfpocBvIP3QgcfO4M1qhx9lL3FmnQd7xJ9gLOgev8PQuVb2e2ddWWm87WVZNSXe6j3U4K_QuZHWw_Up5-jrabXLXoL1x_NrtlwHOiaiD4yRQrFEE14IUJxHVBUqEVySIo4SwoxhnNKUSiEJ5SAEcK2FISlTQqWRInN09-ttO_c9gO_zuvIarJUNuMHnJGZxFCWxoCN6e0IHNd6Yt11Vy-6Y_51DfgCAgWo- |
| CitedBy_id | crossref_primary_10_1002_VIW_20230025 crossref_primary_10_1093_braincomms_fcaf159 crossref_primary_10_1038_s41582_022_00753_3 crossref_primary_10_1159_000547113 crossref_primary_10_1016_j_nicl_2023_103457 |
| ContentType | Journal Article |
| Copyright | 2021 by the Society of Nuclear Medicine and Molecular Imaging. |
| Copyright_xml | – notice: 2021 by the Society of Nuclear Medicine and Molecular Imaging. |
| CorporateAuthor | Alzheimer’s Disease Neuroimaging Initiative |
| CorporateAuthor_xml | – name: Alzheimer’s Disease Neuroimaging Initiative |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.2967/jnumed.120.252783 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1535-5667 |
| ExternalDocumentID | 33097630 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: U01 AG024904 |
| GroupedDBID | --- -~X .55 29L 2WC 53G 5RE 8R4 8R5 8WZ A6W ABSQV ACGOD ACIWK ACPRK ADDZX ADMOG AENEX AFOSN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS CGR CS3 CUY CVF DIK DU5 E3Z EBD EBS ECM EIF EJD EMOBN F5P F9R H13 I-F INIJC KQ8 L7B NPM OK1 P2P Q2X R0Z RHI RNS RWL SJN SV3 TAE TR2 TSM TUS W8F WH7 WOQ X7M YHG 7X8 |
| ID | FETCH-LOGICAL-c427t-ffa7b58c26d7eb6613bdb876a2d41825ff563393a7a236e77e6cc7f295b7b91b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000658151100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1535-5667 |
| IngestDate | Fri Sep 05 06:10:12 EDT 2025 Thu Apr 03 07:00:49 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | 18F-FDG PET conversion pattern Thal phase Braak tangle stage amyloid PET |
| Language | English |
| License | 2021 by the Society of Nuclear Medicine and Molecular Imaging. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c427t-ffa7b58c26d7eb6613bdb876a2d41825ff563393a7a236e77e6cc7f295b7b91b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://jnm.snmjournals.org/content/jnumed/62/6/855.full.pdf |
| PMID | 33097630 |
| PQID | 2454118473 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2454118473 pubmed_primary_33097630 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-06-01 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of nuclear medicine (1978) |
| PublicationTitleAlternate | J Nucl Med |
| PublicationYear | 2021 |
| SSID | ssj0006888 |
| Score | 2.3907223 |
| Snippet | Voxel-based principal-component analysis allows for an identification of patterns of glucose metabolism and amyloid deposition related to the conversion from... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 855 |
| SubjectTerms | Aged Alzheimer Disease - diagnostic imaging Alzheimer Disease - metabolism Alzheimer Disease - pathology Cognitive Dysfunction - diagnostic imaging Cognitive Dysfunction - metabolism Cognitive Dysfunction - pathology Female Fluorodeoxyglucose F18 Humans Image Processing, Computer-Assisted - methods Male Middle Aged Neuroimaging Positron-Emission Tomography Principal Component Analysis |
| Title | Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33097630 https://www.proquest.com/docview/2454118473 |
| Volume | 62 |
| WOSCitedRecordID | wos000658151100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAGB3UinhxX-rGCF7HtrNkkpNobfFgS9EqvZVZRalJNVXw3_tNkuJJELwEcggMk295877hPYTOYi9c0zhNXOwZ4REPlwCMJcIH-O4TSQux58db2e_Ho1EyqAi3vLpWOa-JRaG2mQkceYNywQEMc8kupm8kuEaF6WplobGIagygTIhqOfpRC4_iwncSkloQgC2ynGrSJJKNlxRS3563KLyL4DbxO8IsOk13_b9r3EBrFcbEl2VQbKIFl26hlV41Rd9GT4OSYVcTEspBlkLjwXN1EnIFfc3iXskd5jjzeNAZ4ms1U7g9yXI3-cJ3zge2HxfKHsHTuKygGJBr8DzC9xAJry7fQQ_dzrB9QyrDBWI4lTPivZJaxIZGNlilQKfXVkO5VNRyOIcI70XEWMKUVJRFTkoXGSM9TYSWOmlpuouWUlj0PsKtltLcCqmb3nKVeB0ER-FwYpQ1iaWujk7nWziGgA5TCpW67CMf_2xiHe2V_2E8LZU3xow1AT6x5sEfvj5EqzTcPykYkyNU85DO7hgtm8_Zc_5-UkQKPPuD3jcI4Mm2 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Principal-Component+Analysis-Based+Measures+of+PET+Data+Closely+Reflect+Neuropathologic+Staging+Schemes&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Blazhenets%2C+Ganna&rft.au=Frings%2C+Lars&rft.au=S%C3%B6rensen%2C+Arnd&rft.au=Meyer%2C+Philipp+T&rft.date=2021-06-01&rft.eissn=1535-5667&rft.volume=62&rft.issue=6&rft.spage=855&rft_id=info:doi/10.2967%2Fjnumed.120.252783&rft_id=info%3Apmid%2F33097630&rft_id=info%3Apmid%2F33097630&rft.externalDocID=33097630 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-5667&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-5667&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-5667&client=summon |